These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29772485)

  • 21. An empirical evaluation of the MATRICS Consensus Cognitive Battery in bipolar disorder.
    Van Rheenen TE; Rossell SL
    Bipolar Disord; 2014 May; 16(3):318-25. PubMed ID: 24119238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurocognitive Assessments Are More Important Among Adolescents Than Adults for Predicting Psychosis in Clinical High Risk.
    Zhang T; Cui H; Wei Y; Tang X; Xu L; Hu Y; Tang Y; Chen T; Li C; Wang J
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Jan; 7(1):56-65. PubMed ID: 34274517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between negative symptoms and MATRICS neurocognitive domains: A meta-analysis and systematic review.
    Au-Yeung C; Penney D; Rae J; Carling H; Lassman L; Lepage M
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110833. PubMed ID: 37482283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia.
    Strauss GP; Chapman HC; Keller WR; Koenig JI; Gold JM; Carpenter WT; Buchanan RW
    J Psychiatr Res; 2019 May; 112():38-43. PubMed ID: 30849617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis.
    Catalan A; Salazar de Pablo G; Aymerich C; Damiani S; Sordi V; Radua J; Oliver D; McGuire P; Giuliano AJ; Stone WS; Fusar-Poli P
    JAMA Psychiatry; 2021 Jun; 78(8):859-67. PubMed ID: 34132736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Models of mild cognitive deficits in risk assessment in early psychosis.
    Zhang T; Cui H; Tang X; Xu L; Wei Y; Hu Y; Tang Y; Wang Z; Liu H; Chen T; Li C; Wang J
    Psychol Med; 2024 Jul; 54(9):2230-2241. PubMed ID: 38433595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis.
    Carrión RE; McLaughlin D; Auther AM; Olsen R; Correll CU; Cornblatt BA
    Psychol Med; 2015 Nov; 45(15):3341-54. PubMed ID: 26169626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive course in first-episode psychosis and clinical correlates: A 4 year longitudinal study using the MATRICS Consensus Cognitive Battery.
    Kenney J; Anderson-Schmidt H; Scanlon C; Arndt S; Scherz E; McInerney S; McFarland J; Byrne F; Ahmed M; Donohoe G; Hallahan B; McDonald C; Cannon DM
    Schizophr Res; 2015 Dec; 169(1-3):101-108. PubMed ID: 26416442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cognitive functions between first-episode schizophrenia patients, their unaffected siblings and individuals at clinical high-risk for psychosis.
    Chu AOK; Chang WC; Chan SKW; Lee EHM; Hui CLM; Chen EYH
    Psychol Med; 2019 Aug; 49(11):1929-1936. PubMed ID: 30226125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive Auditory Cognitive Training Improves Verbal Memory in Adolescents and Young Adults at Clinical High Risk for Psychosis.
    Loewy R; Fisher M; Schlosser DA; Biagianti B; Stuart B; Mathalon DH; Vinogradov S
    Schizophr Bull; 2016 Jul; 42 Suppl 1(Suppl 1):S118-26. PubMed ID: 26903238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive Function and Variability in Antipsychotic Drug-Naive Patients With First-Episode Psychosis: A Systematic Review and Meta-Analysis.
    Lee M; Cernvall M; Borg J; Plavén-Sigray P; Larsson C; Erhardt S; Sellgren CM; Fatouros-Bergman H; Cervenka S
    JAMA Psychiatry; 2024 May; 81(5):468-476. PubMed ID: 38416480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between age and neurocognition in individuals at clinical high risk and first-episode psychosis.
    Zhang T; Wei Y; Cui H; Tang X; Xu L; Hu Y; Tang Y; Liu H; Chen T; Li C; Wang J
    Psychiatry Res; 2023 Sep; 327():115385. PubMed ID: 37567111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcome.
    Rodriguez-Toscano E; López G; Mayoral M; Lewis S; Lees J; Drake R; Arango C; Rapado-Castro M
    Schizophr Res; 2020 Feb; 216():347-356. PubMed ID: 31813804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia.
    Fervaha G; Hill C; Agid O; Takeuchi H; Foussias G; Siddiqui I; Kern RS; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):304-9. PubMed ID: 26004693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurocognitive profile in major depressive disorders: relationship to symptom level and subjective memory complaints.
    Mohn C; Rund BR
    BMC Psychiatry; 2016 Apr; 16():108. PubMed ID: 27095362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of cognitive impairment with quality of life and functional impairment in Ugandan first-episode psychosis patients: a cross sectional study.
    Mwesiga EK; Ssemata AS; Gumikiriza J; Nanteza A; Nakitende AJ; Nakku J; Akena D; Nakasujja N
    Health Qual Life Outcomes; 2022 Jul; 20(1):113. PubMed ID: 35870969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A longitudinal study of neurocognitive function in individuals at-risk for psychosis.
    Keefe RS; Perkins DO; Gu H; Zipursky RB; Christensen BK; Lieberman JA
    Schizophr Res; 2006 Dec; 88(1-3):26-35. PubMed ID: 16930949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study.
    Olivier MR; Killian S; Chiliza B; Asmal L; Schoeman R; Oosthuizen PP; Kidd M; Emsley R
    Psychol Med; 2015 Oct; 45(13):2873-83. PubMed ID: 25998030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study.
    Kern RS; Gold JM; Dickinson D; Green MF; Nuechterlein KH; Baade LE; Keefe RS; Mesholam-Gately RI; Seidman LJ; Lee C; Sugar CA; Marder SR
    Schizophr Res; 2011 Mar; 126(1-3):124-31. PubMed ID: 21159492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.